News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, May 11, 2020

COVID-19 ANNOUNCEMENTS are below.

 

 

Plan for Phase One Reopening of Research at OUHSC

The return to full, normal operations of research will be a gradual, phased process.  In accordance with the

OUHSC COVID-19 Return Plan the OUHSC Vice President for Research is announcing a Phase One Reopening

of Research that will begin starting Monday, May 11.  Information on the reopening of research at OUHSC

can be found at:  https://research.ouhsc.edu/Resources/COVID-Research-Updates

 

 

Updated Costing and Financial Compliance FAQs have been posted on COGR's FAQs and Resources on

COVID-19's Impact to Federal Awards web page.

https://www.cogr.edu/cogrs-faqs-and-resources-covid-19s-impact-federal-awards

 

 

Please see an additional opportunity through NIH’s National institute of Biomedical Imaging and Bioengineering

(NIBIB) for soliciting proposals focused on rapid production of innovative SARS-CoV-2 diagnostic tests.  Information

regarding this solicitation can be found at https://www.poctrn.org/radx.

 

 

HRSA is pleased to announce the Rural Tribal COVID-19 Response program funding opportunity found

here: https://www.grants.gov/web/grants/view-opportunity.html?oppId=326385

Through the Coronavirus Aid, Relief, and Economic Security (CARES) Act, HRSA received $15M to allocate to tribes, tribal

organizations, urban Indian health organizations, and health service providers to tribes. The funding will provide support for

the Tribes to prevent, prepare, and respond to COVID-19 in rural communities. Tribes can request up to $300K in funding

for COVID-19 related activities. For this funding opportunity, the System for Award Management (SAM) registration

requirements will be relaxed for applicants at the time of submission in Grants.gov. Current registrants in SAM, with active

registrations expiring before May 16, 2020, will be provided a one-time extension of 60 days. New applicants are able to

submit an application without a valid SAM registration.

Applicants can reach out to RuralCOVIDNOFO@hrsa.gov with any questions or concerns regarding their submission.

To learn more about HRSA’s Federal Office of Rural Health Policy’s response to COVID-19, visit,

https://www.hrsa.gov/rural-health/coronavirus-frequently-asked-questions

 

 

Attention Certificate of Confidentiality (CoC) Holders:  Please note that if you currently have a certificate of

confidentiality for your project involving human subject research, NIH has automatically extended expiration dates.  

If you have a current CoC as of April 15, 2020, it has automatically been extended for 12 months.  For more information,

please click this link 

https://grants.nih.gov/grants/files/notice-automatic-certificate-extension-covid19.pdf

 

 

The National Science Foundation (NSF) is accepting proposals to conduct non-medical, non-clinical-care research

that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate

about the science of virus transmission and prevention, and to encourage the development of processes and actions to

address this global challenge. These proposals may be submitted through regular programs and/or through the RAPID

mechanism, which allows program officers to directly award up to $200,000 for projects lasting up to 24-months. These

can turn around in a matter of weeks. As an EPSCoR state, Oklahoma has a slight edge in this funding. As well, females

and members of underrepresented populations are encouraged to apply.

https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.pdf

 

 

Fast-Grants – Fast Funding for COVID-19 Science

https://fastgrants.org/

 

 

NIH has created a central site for its current COVID-19 guidance at

https://grants.nih.gov/policy/natural-disasters/corona-virus.htm

 

 

The National Human Genome Research Institute (NHGRI) issued a Notice of Special Interest (NOSI) to solicit

research proposals focused on “a better understanding of host response, associated diseases, and short- and long-term

clinical outcomes of individuals infected with SARS-CoV2.”  Research interests include but are not limited to the

development of novel methods using genomic techniques to identify signatures of infection, prognosis, and severity of

disease, development of novel genomic-based tools, kits or reagents to track and monitor SARSCoV-2 infected individuals,

and use of tools to understand the genetic epidemiology of SARSCoV-2.  Additional details and application and submission

details can be found in the Notice.  Investigators can apply for both Administrative Supplements and Urgent Competitive

Revisions through this NOSI.

https://grants.nih.gov/grants/guide/notice-files/NOT-HG-20-034.html

 

 

Oklahoma Tobacco Settlement Endowment Trust (TSET) – Updated Guidance for Invoice Policies and

Procedures During COVID-19 Pandemic

https://content.govdelivery.com/accounts/OKTSET/bulletins/28596f2

 

 

OCAST Application Review and Award Contract Management Issues Related to COVID-19

Frequently asked Questions can be found at:

https://www.ok.gov/ocast/RESOURCES/COVID-Related-FAQs.html

 

 

OUHSC Financial Administrators:

The federal and state governments are asking that all institutions track their expenditures related to the

COVID-19 pandemic.  It is imperative that everyone is diligent in tracking all COVID-19-related expenditures for future 

reimbursement opportunities.  Effective immediately, all COVID-19-related expenditures incurred since March 12 should be

coded to a newly created COVID subclass. These expenditures include, but are not limited to direct COVID-19 costs,

increased housekeeping and maintenance costs, expenditures related to business process modifications, preparatory

actions, daily operations, and communications resulting from COVID-19.  If COVID related expenses, since March 12,

have already been paid, please process a cost transfer using the new COVID subclass.Research faculty and staff should

also track their expenditures incurred by the shutdown of their projects and laboratories including the loss of samples,

reagents, animals and other items.   Also, keep in mind that, as you resume your activities in your lab, any expenses

required to restart the lab should be coded with the COVID subclass.  This will help significantly when applying for any a

dministrative supplements or other COVID-19 related relief efforts. Questions regarding the use of the subclass on

non-research chartfields should be forwarded to judy-olson@ouhsc.edu and research related questions can be sent to 

tamara-franklin@ouhsc.edu.

 

 

OUHSC Funding Requests related to COVID-19 – when submitting an item in the OUHSC SoonerTrack system

related to COVID-19 please include “COVID-19” in the title so that we are able to search on it later.

 

 

Patient-Centered Outcomes Research Institute (PCORI)

PCORI is monitoring the impact of the novel coronavirus and cases of COVID-19 to determine whether they need to alter

key dates associated with PCORI Funding Announcements (PFAs). Recognizing the challenges presented by the

pandemic and after careful consideration, they will release the Phased Large Awards for Comparative Effectiveness

Research PFA on June 9, 2020. The new deadline for required Letters of Intent will be September 29, 2020. Those invited

to submit a full application will have until January 12, 2021. These new dates correspond to PCORI’s Cycle 3 2020 timeline. 

Please feel free to share this information with anyone who may be interested.

https://www.pcori.org/funding-opportunities/announcement/phased-large-awards-comparative-effectiveness-research-cycle-3-2020?utm_source=placer&utm_medium=email&utm_campaign=030420 

 

 

Department of Defense – Supplemental Guidance on Administrative Flexibilities for Grants and Cooperative

Agreements in Response to COVID-19 Pandemic 

https://basicresearch.defense.gov/COVID-19/Frequently-Asked-Questions/

 

 

COVID-19/Coronavirus Resources – a list from InfoEd

https://www.infoedglobal.com/COVID19/COVID-19.html

 

 

Notice of Special Interest (NOSI) Regarding the Availability of Urgent Competitive Revisions for Research

on Coronavirus Disease 2019 (COV-19) and the Causative Virus SARS-CoV-2 (NOT-GM-20025)

https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html

 

 

DONATION OF TESTING SUPPLIES

OU Physicians has requested that researchers look into their supplies and see whether they can donate any of the Testing

supplies listed in the attached “Testing Donations”.  Please return the complete form to Kristen.Namey@oumedicine.com

https://research.ouhsc.edu/Portals/1329/Assets/Documents/Testing Donations.xlsx?ver=2020-03-23-093320-937

 

DONATION OF PPE SUPPLIES

OU Physicians has requested that researchers look into their supplies and see whether they can donate any of the PPE

supplies listed in the attached “research PPE donation”.  The first line is an example of how to fill out the form. 

Please return completed form to Erin-Bailey@ouhsc.edu.

URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/Copy of research PPE donation.xlsx?ver=2020-03-23-093320-780

 

OUHSC Colleagues:   Attached is a memo from The Jackson Laboratory to assist researchers with preserving valuable

lines which might be lost during the pandemic situation, and for which may not be in their existing 11,000 line storage locker for

researcher access. The OUHSC Department of Comparative Medicine can assist with animal preparation for ship out of your line(s).

URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/JAXLabs_04202020.docx?ver=2020-04-13-115833-513

Office of Technology Commercialization presents a new opportunity to engage with industry

(click http://www.ou.edu/otc/ICO for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu for specific

submission details): Boston Scientific is looking to engage with academia for developing novel diagnostics & therapeutics for inflammatory bowel

disease.  Focus areas include:

  1. Solutions that target all complications due to Crohn’s disease and colitis
  2. Delivery methods: endoscopic, minimally invasive solutions
  3. External technologies: wearable, self-diagnostics, symptom-tracking apps
  4. Prefer focused devices/concepts (will consider combination devices/concepts)
  5. OUT OF SCOPE: surgical, laparoscopy, and pharmaceutical solutions

Highest priority is research with initial prototype/proof of concept through to clinical testing.

Non-confidential summary application (~template available~) due June 8th, 2020.

 

 

REQUEST FOR LETTERS OF INTENT- BRAIN RESEARCH FOUNDATION/SCIENTIFIC INNOVATIONS AWARD

The University of Oklahoma Health Sciences Center is seeking Letters of Intent (LOI) from Associate or Full Professors for the

Scientific Innovation Award (SIA) sponsored by the Brain Research Foundation (BRF). The LOI will be due May 22, 2020 to the

Vice-President for Research (VPR@OUHSC.edu) and only one LOI will be selected for submission to the Brain Research

Foundation. The BRF provides funding for innovative science in both basic and clinical neuroscience. The objective of the SIA

is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood

of producing important findings. It is expected that investigations supported by these grants will yield high impact findings and

result in major grant applications and significant publications in high impact journals. The SIA award is limited to $150,000

(total direct costs) for a two year grant period. Only one PI may apply per application (multi-PI grants are not allowed). 

Please see the attachment BRF Request for Applications for full details.

URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/BRF_REQUEST FOR APPLICATIONS.pdf?ver=2020-05-04-095853-197

 

Kidney Cancer Association (KCA) annual grant program for clinicians and scientists doing innovative

research in kidney cancer. The KCA supports two types of grants:

  • Advanced Discovery Awards (two awards, $500,000 each)
  • Young Investigator Awards (four awards, $75,000 each)

Applications are open now. Deadline for both programs is August 5, 2020. Linked below are the press release and the grants

information and submission page.

Press release: https://www.kidneycancer.org/the-kidney-cancer-association-seeks-applicants-for-1-3-million-in-grant-funding/

Information and submission page: https://kidneycancer.submittable.com/submit

 

 

National Institutes of Health (NIH) - This message is a reminder that grant applicants must use FORMS-F for all

application due dates on or after May 25, 2020. ASSIST has been updated to support the new application forms (FORMS-F)

and eRA is ready to process those applications submitted using FORMS-F.

 

 

The 2020 BeHEARD (Helping Empower and Accelerate Research Discoveries) Challenge is hosted annually

by the Rare Genomics Institute and is open globally to researchers, foundations, or anyone whose research is constrained

due to limited resources. This year, we have over $85,000 of technologies available for researchers. They collaborate with

companies to provide free technology grants including mouse models, genome analysis software, antibodies and plasmids.

Applicants select one or more technologies that they think would benefit their research, and submit a proposal for each

technology. Research proposals are evaluated based on the technology's fit with the research and the potential for the

research to advance rare disease treatments. The application is short (~2 pages) and very straightforward. For more

information on the competition and the application, please visit our website: http://www.raregenomics.org/beheard-competition/.

The deadline for applications is May 31, 2020. 

 

 

Oklahoma Medical Research Foundation – Expanding Excellence in Developmental Biology in Oklahoma CoBRE

Pilot Projects – Deadline May 31, 2020.  See attached document for additional information.

URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/OMRF_Call for COBRE Pilot Project Proposals.pdf?ver=2020-02-17-074940-847

 

The Oklahoma Center for Microbial Pathogenesis and Immunity COBRE – Pilot Project Awards

Deadline extended to May 15, 2020.  For additional information see the attached document.

URL: https://research.ouhsc.edu/Portals/1329/Assets/Documents/Micro_COBRE Pilot RFA 032320.pdf?ver=2020-03-29-114558-020

 

Attention: OUHSC FY20 State Contract Budget Planning

F&A (IDC) are real costs incurred by the department and the University in support of sponsored activities.  The funding

derived from F&A provides critical dollars necessary to support the operating expenses related to the space in which the

project is conducted, as well as the various services provided to the Principal Investigator and the college and department

for administering the contract (e.g., accounting, purchasing, human resources). Without appropriate recovery of F&A costs,

The University loses money and we must be fiscally responsible to our tax payers and students.  It is not responsible

stewardship to waive these costs. Since this is the time of year when a lot of departments and faculty start their FY21

budget planning for their anticipated state contracts, we wanted to remind everyone that no F&A reduction or waiver

requests will be approved this year.  As always, Please see this link for current F&A rates:

https://research.ouhsc.edu/Research-Administration/Forms-and-Rates/F-A-Rates

To review OUHSC Facilities and Administration Policy for Externally Funded Projects, please see this link:

https://www.ouhsc.edu/policy/#19931993-section-572---university-of-oklahoma-health-sciences-center-facilities-and-administrative-costs-policy-for-externally-funded-projects

 

 

NIH NOTICES

 

Notice of Changes in NCI K00 Salary Caps in The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

(NOT-CA-20-049)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-049.html

 

Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects

to be Redirected to COVID-19-related Research During the Crisis (NOT-CA-20-054)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-054.html

 

Notice of a Joint Veterans Health Administration/National Cancer Institute Data Science Postdoctoral Fellowship –

the Big Data Scientist Training Enhancement Program (BD-STEP) (NOT-CA-20-058)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-058.html

 

Pre-Application Webinar for RFA-CA-20-030, Utilizing Cohort Studies to Address Health Outcomes in Cancer Survivors

(UG3/UH3 Clinical Trial Not Allowed) (NOT-CA-20-059)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-059.html

 

Pre-Application Webinar for RFA-HG-20-001 and RFA-HG-20-002, Polygenic Risk Score (PRS) Methods and Analysis

for Populations of Diverse Ancestry Study Sites and Coordinating Center (U01 Clinical Trial Not Allowed) (NOT-HG-20-038)
https://grants.nih.gov/grants/guide/notice-files/NOT-HG-20-038.html

 

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Webinar on

Navigating the NIH for Researchers Interested in DSD and Intersex Populations
(NOT-OD-20-102)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-102.html

 

Request for Information: Soliciting Input for the National Center for Complementary and Integrative Health’s New

Strategic Plan (NOT-AT-20-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-20-013.html

 

Request for Information (RFI): Guidance on Current Clinical Experience in Suicide Prevention in Primary Care

Settings (NOT-MH-20-046)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-046.html

 

Notice to Extend the Expiration Date for PAR-17-170 "Alcohol Research Resource Awards (R24)"
(NOT-AA-20-012)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-20-012.html

 

Notice of Change to PAR-18-538 "Basic and Translation Research on Decision Making in Aging and Alzheimer's

Disease (R21 - Clinical Trial Optional)" (NOT-AG-20-029)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-029.html

 

Notice of Change to PAR-18-544 "Basic and Translational Research on Decision Making in Aging and Alzheimer's

Disease (R01 - Clinical Trial Optional)" (NOT-AG-20-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-030.html

 

Notice of Clarification to Eligibility Information in RFA- AI-20-029 Clinical Trials in Organ Transplantation in Children

and Adults (CTOT-CA) (U01 Clinical Trial Optional) (NOT-AI-20-045)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-045.html

 

Notice of Change in Key Dates for RFA-AI-20-008 , Multidisciplinary Studies to Improve Understanding of Influenza

Transmission (U19 Clinical Trial Optional) (NOT-AI-20-046)
https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-046.html

 

Notice of Change to the Receipt Date of PAR-17-496 and PAR-17-464, "Intervention Research to Improve Native

American Health (R01/R21 Clinical Trial Optional)" (NOT-CA-20-053)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-053.html

 

Notice of Change to Application Due Date for RFA-CA-19-045 "Participant Engagement and Cancer Genome

Sequencing (PE-CGS) (U2C Clinical Trial Optional)" (NOT-CA-20-056)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-056.html

 

Notice of Change to the First Receipt Date of RFA-CA-20-027 and RFA-CA-20-028, "Research to Reduce Morbidity

and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01/R21 Clinical Trial Optional)"

(NOT-CA-20-057)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-057.html

 

Notice of An Additional Cycle of Receipt Dates Added to RFA-DA-20-028 Implementing the HIV Service Cascade for

Justice-Involved Populations (U01 Clinical Trial Required)" (NOT-DA-20-051)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-051.html

 

Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent

Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK" (NOT-DK-20-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-20-026.html

 

Notice of Correction to NOT-EY-20-005: Notice of NEI Participation in PAR-19-091 "NIH Research Project Grant

(Parent R01 Basic Experimental Studies with Humans Required)" (NOT-EY-20-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-EY-20-007.html

 

Notice of Correction to NOT-EY-20-006: NEI Participation in PAR-19-092 "NIH Exploratory/

Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)"(NOT-EY-20-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-EY-20-008.html

 

Notice to Extend Application Due Date for RFA-FD-20-027 "Integrated Pathogen Reduction Technologies for Whole Blood and

Blood Components for Transfusion (R01) Clinical Trial Not Allowed" (NOT-FD-20-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-FD-20-026.html

 

Notice of Change in Application Due Date for RFA-HL-21-011, Stimulating T4 Implementation Research to Optimize Integration

of Proven-effective Interventions for HLB Diseases and Sleep Disorders into Practice (STIMULATE-2) (R61/R33 Clinical Trial

Required) (NOT-HL-20-783)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-783.html

 

Notice of Change to the Award Project Period for PAR-19-197 "Summer Research Education Experience Program

(R25 Clinical Trial Not Allowed)" (NOT-NS-20-050)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-050.html

 

Notice of Extension of Expiration Date for PAR-17-456 "CREATE Bio Optimization Track for Biologics (U01 Clinical Trial

Not Allowed)" (NOT-NS-20-053)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-053.html

 

Notice of Extension of Expiration Date for PAR-17-457 "CREATE Bio Optimization Track for Biologics (SBIR) (U44 Clinical

Trial Not Allowed)" (NOT-NS-20-054)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-054.html

 

Notice of Extension of Expiration Date for PAR-18-542 "CREATE Bio Development Track: Nonclinical and Early-Phase Clinical

Development for Biologics (U01 Clinical Trial Optional)" (NOT-NS-20-055)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-055.html

 

Notice of Extension of Expiration Date for PAR-18-543 "CREATE Bio Development Track: Nonclinical and Early-Phase Clinical

Development for Biologics (U44 Clinical Trial Optional)" (NOT-NS-20-056)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-056.html

 

Notice of Change to Key Dates for PAR-19-211 "NINDS Institutional Research Training Program (T32)"
(NOT-NS-20-059)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-059.html

 

Notice of Change to Key Dates for PAR-19-228 "Institutional Translational Research Training Program (T32)" (NOT-NS-20-060)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-060.html

 

Notice of Change to Key Dates for PAR-20-076 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award

Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)" (NOT-NS-20-061)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-061.html

 

Notice of Correction to Key Dates for RFA-NS-20-029 "BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs –

eTeamBCP (U01 Clinical Trials Optional)" (NOT-NS-20-063)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-063.html

 

Notice of Change to Key Dates for PAR-18-469 "NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity

in Neuroscience Research (K22-No Independent Clinical Trials)" (NOT-NS-20-065)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-065.html

 

Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational

Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need (NOT-TR-20-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-018.html

 

Notice to Extend the Expiration Date for PAR-17-465 "Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)"

(NOT-TR-20-025)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-025.html

 

Notice to Extend the Expiration Date for PAR-18-332 "Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical

Trial Required)" (NOT-TR-20-026)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-026.html

 

Notice to Extend the Expiration Date for PAR-18-462 "Clinical Trial Planning: Therapeutic/Indication Pairing Strategies

(U34) (Clinical Trial Not Allowed)" (NOT-TR-20-027)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-027.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers of Excellence for

Parkinson's Disease Research (P50 Clinical Trial Optional) (NOT-NS-20-057)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-057.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Exploratory Grant Program in Parkinson's

Disease Research (P20- Clinical Trial Optional) (P20 Clinical Trial Optional) (NOT-NS-20-058)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-058.html

 

Notice of Special Interest (NOSI): Administrative Supplement to a Cancer Moonshot Coordinating Center (U24) to Support

the Mechanisms of Cancer Drug Resistance and Sensitivity Network (DSRN)
(NOT-CA-20-052)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-052.html

Notice of Special Interest (NOSI): Implementation of Clinical Care Guidelines on Opioid Prescribing for Pain Management

(NOT-DA-20-038)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-20-038.html

 

Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Trials

(NOT-HL-20-755)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-755.html

 

Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation in Childhood

(NOT-HL-20-761)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-761.html

 

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19)

for Currently Active NHLBI Phase I-III Clinical Trials (NOT-HL-20-782)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-20-782.html

 

Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21)
(NOT-LM-20-011)
https://grants.nih.gov/grants/guide/notice-files/NOT-LM-20-011.html

 

Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For

Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System
(NOT-NS-20-051)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-20-051.html

 

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute

Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-RM-20-015.html

 


Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least two months prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements

to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)

(PA-20-070) - Deadline May 29, 2020  

https://grants.nih.gov/grants/guide/pa-files/PA-20-070.html

 

Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and

Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19

(Supplement - Clinical Trial Optional) (PA-20-072) - Deadline May 29, 2020 

https://grants.nih.gov/grants/guide/pa-files/PA-20-072.html

 

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and

Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) (PAR-20-177)
Deadline: Applications will be accepted on a rolling basis, beginning April 30, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-177.html

 

Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and

Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) (PAR-20-178)
Deadline: Applications will be accepted on a rolling basis, beginning April 30, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-178.html

 

Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity

(R01 Clinical Trial Optional) (PAR-20-179) – Deadline October 05, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-179.html

 

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences

(R01 Clinical Trial Optional) (PAR-20-180) – Deadline October 05, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-20-180.html

 

Coordinating Unit to Support the Kidney, Urology and Hematology (KUH) Innovative Science Accelerator Program

(ISAC-CU) (U24 Clinical Trial Not Allowed) (RFA-DK-20-010) - Deadline August 4, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-010.html

 

U.S. - India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional)
(RFA-ES-20-010) - Deadline October 15, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-20-010.html

 

Superfund Research Program Occupational Health and Safety Education Programs on Emerging Technologies

(R25 - Clinical Trial Not Allowed) (RFA-ES-20-011) – Deadline August 3, 2020  

https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-20-011.html

 

Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) Disease

Modifying Therapies for Chronic Lung Diseases (U24 Clinical Trial Required - Infrastructure)
(RFA-HL-21-012) – Deadline July 24, 2020  

https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-21-012.html

 

Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)
(RFA-HL-21-013) – Deadline July 24, 2020 and June 01, 2021  

https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-21-013.html

 

 

OTHER DEADLINES

 

Department of Defense (DOD) – Melanoma Research Program (MRP) – Idea Award – Required Preapplication

Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD – MRP – Mid-Career Accelerator Award – Required Preapplication Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD - MRP – Team Science Award – Required Preapplication Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD - MRP – Technology Development Partnership Award – Required Preapplication Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD - MRP – Translational Research Award – Required Preapplication Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD - MRP – Translational Research Award (Collaborator Option) – Required Preapplication Due June 22, 2020

https://cdmrp.army.mil/funding/mrp

 

DOD – Multiple Sclerosis Research Program (MSRP) – Clinical Trial Award – Required Preapplication Due June 17, 2020

https://cdmrp.army.mil/funding/msrp

 

DOD – MSRP – Exploration Hypothesis Development Award – Required Preapplication Due June 17, 2020

https://cdmrp.army.mil/funding/msrp

 

DOD – MSRP – Investigator Initiated Research Award – Required Preapplication Due June 17, 2020

https://cdmrp.army.mil/funding/msrp

 

District Attorney Council – 2020 Coronavirus Emergency Supplemental Funding Grant – Currently no Deadline

https://www.ok.gov/dac/Grants/Grants_Available/Grants:_Coronavirus_Emergency_Supplemental_Funding_(CESF).html

 

Oklahoma Center for Adult Stem Cell Research (OCASCR) – Grant Deadline is September 15, 2020

http://www.ocascr.org/grants/grant-application-information/

 

Print